RTI.V - Radient Technologies Inc.
Chart Events
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 0.1850 |
| Open | 0.1800 |
| Bid | 0.1650 x N/A |
| Ask | 0.1750 x N/A |
| Day's Range | 0.1600 - 0.1800 |
| 52 Week Range | 0.1250 - 0.9900 |
| Volume | 2,120,204 |
| Avg. Volume | 546,168 |
| Market Cap | 47.205M |
| Beta (5Y Monthly) | 1.79 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1000 |
| Earnings Date | Jul 06, 2020 - Jul 10, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Related Research
- GlobeNewswire
Radient Announces Successful Closing of its Equity Offering for Gross Proceeds of $5,750,000
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) is pleased to announce that it has closed its public equity financing initially announced on May 20, 2020. The Company issued 28,750,000 units (the “Units”) of the Company (which includes 3,750,000 Units issued pursuant to the exercise in full of the over-allotment option) at a price of $0.20 per Unit (the “Offering Price”) for aggregate gross proceeds of $5,750,000 (the “Offering”). The Offering was completed by Eight Capital (the “Agent”) as sole agent.
- GlobeNewswire
Radient Technologies Inc. Receives TSXV Approval to Extend Warrants
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, announces that it has received the approval from the TSX Venture Exchange to extend the term of 3,051,310 warrants originally scheduled to expire on June 2, 2020 and 5,872,382 warrants originally scheduled to expire on June 22, 2020 (the “Warrants”) to June 2, 2021 and June 22, 2021, respectively. The Warrants were originally issued pursuant to private placements of units completed by the Company on December 2, 2016 and December 22, 2016. The new expiry date for these warrants is June 2, 2021 and June 22, 2021, respectively.
- GlobeNewswire
Radient Technologies Inc. Launches bioU, a Brand of High Quality Cannabis Extract Formulations Exclusively for Medical Cannabis by Shoppers
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to announce the launch of bioU, a scientifically formulated brand exclusively sold to Medical Cannabis by Shoppers™ (“Shoppers”), a subsidiary of Shoppers Drug Mart Inc., and available across Canada. Radient’s first products released under the bioU label will be the Uspray series of high quality, scientifically formulated oral cannabis sprays.
- GlobeNewswire
Radient Technologies Announces $5 Million Equity Offering
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) is pleased to announce a proposed offering of 25,000,000 units (the “Units”) at an offering price of $0.20 per Unit (the “Issue Price”), for aggregate gross proceeds of up to $5,000,000 (the “Offering”). The Units will be offered on a best efforts basis by Eight Capital, as agent for the Company (the “Agent”), pursuant to a prospectus supplement to Radient’s base shelf prospectus dated January 21, 2020 (collectively, the “Prospectus”). BDO Canada LLP is acting as Radient’s financial advisor in connection with the Offering.
- GlobeNewswire
Radient Technologies Inc. Announces Collaboration on the Development of Anti-Viral Products and Files Patent Application Covering Cannabinoid Based Compositions for the Mitigation and Protection from Viruses
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, announces that it has filed a provisional patent application covering the use of a combination of cannabinoids, terpenes and zinc (the “Formulations”) as a means of preventing infection of coronavirus, mitigating the symptoms of coronavirus, and lowering infectiousness of Covid-19 patients, with the goal of reducing hospitalizations and intensive care unit requirements. Additionally, the Company announces that it will lead a collaboration with two US based groups, IntuitiveX (“IntuitiveX”) and ipCapital Group (“ipCapital”), to explore the development of new anti-viral products using the Formulations.
- Simply Wall St.
Does Radient Technologies Inc. (CVE:RTI) Have A High Beta?
Anyone researching Radient Technologies Inc. (CVE:RTI) might want to consider the historical volatility of the share...
- GlobeNewswire
Radient Technologies Inc. Announces Shares for Debt Arrangements
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, announces that it has entered into a series of shares for debt agreements with various of its creditors under the terms and conditions noted below. The Company has agreed to issue 3,781,073 units to a number of third party creditors in exchange for the settlement of $623,877 of amounts owed by the Company. Each unit will have a deemed value of $0.165 per unit and each unit will include one share and one-half of one common share purchase warrant.
- GlobeNewswire
Radient Technologies Inc. Applies to Extend Warrants
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, has applied to the TSX Venture Exchange (the “TSXV”) to extend the term of 1,070,712 warrants originally scheduled to expire on April 14, 2020 (the “Warrants”) to April 14, 2021. The Warrants were originally issued pursuant to a private placement of units completed by the Company on October 14, 2016. The exercise price of the Warrants will remain at CAD $0.25.
- GlobeNewswire
Radient Announces the Initiation of an At-the-Market Equity Program and Provides an Update on Initiatives to Meet Customer Demand During COVID-19 Pandemic, Financing Activities and Liquidity
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) announces that the Company has established an at-the-market equity program (the “ATM Program”). The Company also announces that it is actively reviewing its operations in response to guidance from governmental and health authorities with a view to limiting the spread of the virus that causes COVID-19, and also wishes to provide an update on its current liquidity and financing activities. The ATM Program will allow the Company to issue up to $9.4 million worth of common shares from treasury (“Common Shares”) to the public from time to time at prevailing market prices through the TSX Venture Exchange (“TSXV”) or any other marketplace on which the Common Shares are listed, quoted or otherwise traded in Canada.
- GlobeNewswire
Allied Corp. and Radient Technologies Inc. Announce Agreement to Facilitate Premium Quality CBD Products to be Sold in Canada
Allied Corp. ("Allied" or the "Company") (OTCQB: ALID), an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today’s medical issues, and Radient Technologies Inc. (“Radient”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, are pleased to announce they have signed a definitive agreement (the “Agreement”) as part of a three way agreement with the Dhaliwal Group (“Dhaliwal”) to manage the supply chain, manufacturing and sale of high quality CBD distillate and isolate. Under the terms of the Agreement, Allied will facilitate the supply and purchase of high quality CBD distillate and isolate between licensed cultivators and licensed buyers.
- Simply Wall St.
Shareholders Are Thrilled That The Radient Technologies (CVE:RTI) Share Price Increased 290%
The last three months have been tough on Radient Technologies Inc. (CVE:RTI) shareholders, who have seen the share...
- GlobeNewswire
Radient Technologies Inc. Receives License Amendment from Health Canada for its Edmonton II Facility and Closes First Tranche of its Previously Announced Debenture Financing
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to announce that Health Canada has approved the Company’s application to amend its existing Standard Processors License to include its Edmonton II facility for the processing of cannabis materials. Radient’s Edmonton II Facility (“Edmonton II”), which the Company has retrofitted to accommodate the extraction and downstream processing of CBD from hemp, was designed to process both cannabis and hemp materials to produce high quality cannabinoid extracts.
- GlobeNewswire
Radient Technologies Inc. Reports Record Revenue and Record Gross Profit for the Third Quarter of Fiscal 2020
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to report its financial results for the third quarter of its fiscal year 2020, ended December 31, 2019. The financial statements and Management’s Discussion & Analysis are available under the Company’s profile at www.SEDAR.com.
- GlobeNewswire
Radient Technologies Inc. Signs Supply Agreement with Medical Cannabis by Shoppers, a subsidiary of Shoppers Drug Mart Inc., for the Formulation and Manufacturing of Exclusive Branded Cannabis Products
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to announce it has entered into a supply agreement (the “Agreement”) with Medical Cannabis by Shoppers, the online medical cannabis platform of leading Canadian pharmacy retailer Shoppers Drug Mart (“Shoppers”). Under the terms of the Agreement, Radient will utilize its proprietary extraction and downstream processing platform to create a variety of cannabinoid formulations under a brand that will be sold exclusively to patients of Medical Cannabis by Shoppers.
- GlobeNewswire
Radient Technologies Inc. Announces up to CAD $15.4 Million in Debenture Financings and Provides Corporate Update
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to announce a total financing package of up to CAD $15,400,000 through the issuance of up to $10.4 million of unsecured convertible notes (the “Notes”) and up to $5 million of unsecured debentures (the “Debentures”). Attached to the Notes will be share purchase warrants with the terms described below (the “Warrants”).
- GlobeNewswire
Radient Technologies Inc. Announces Changes to its Board of Directors
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, announces the following changes to its Board of Directors, effective today. Radient is pleased to announce that Health Canada has approved the addition of Ms. Jocelyne F. Lafrenière and Mr. Yves Gougoux to its Board of Directors, effective today.
CNW GroupAurora Cannabis Announces Appointment of Two New Independent Directors
Aurora Cannabis Announces Appointment of Two New Independent Directors
CNW GroupAurora Cannabis Announces CEO Retirement and Succession, Board of Directors Expansion, and Business Transformation Plan
EDMONTON , Feb. 6, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced a CEO succession and Board expansion; the latter of which is detailed in a separate announcement released this afternoon. The Company also announced a business transformation plan that better aligns selling, general & administrative expenses, and capital expenditures with current market conditions.
CNW GroupAurora Cannabis Receives EU GMP Certification for its Aurora River Facility
Aurora Cannabis Receives EU GMP Certification for its Aurora River Facility
- Simply Wall St.
Is Radient Technologies Inc.'s (CVE:RTI) CEO Salary Justified?
Denis Taschuk became the CEO of Radient Technologies Inc. (CVE:RTI) in 2011. This report will, first, examine the CEO...
- GlobeNewswire
Radient Technologies Inc. Signs Binding Letter of Intent to Enter into Sale-Leaseback Financing Agreement and Reaffirms Revenue Guidance of at Least $10 Million for Fiscal Q3 2020
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, is pleased to announce it has entered into a binding Letter of Intent (the “LOI”) for a Sale-Leaseback transaction in which 2238501 Alberta Ltd. (the “Purchaser”) would purchase from Radient the land and buildings (collectively, the “Land”) comprising the Company’s Edmonton I, II, and III facilities (the “Transaction”).
CNW GroupAurora Cannabis Provides Corporate Update and Confirms Cannabis 2.0 Roll Out
EDMONTON , Dec. 23, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today provided an update on the readiness of its operations with the introduction of new product formats, recent industry recognitions and updates to existing operations. As a global leader in cannabis revenues, cannabis production, research, innovation and international market development, the Company intends to provide regular updates to its stakeholders in an effort to demonstrate continued transparency and disclosure.
CNW GroupAurora Cannabis Announces Change to Executive Team: Cam Battley Steps Away From his Role as Chief Corporate Officer
EDMONTON , Dec. 21, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE │ TSX: ACB), the Canadian company defining the future of cannabis worldwide, announces a change to the Executive Team. Cam Battley has stepped down as Chief Corporate Officer effective December 20, 2019 . Mr. Battley joined Aurora in 2016, serving a number of senior roles critical to the success of the company in its early years before being named Chief Corporate Officer in 2018.
